Maynard Um
-
-
-
-
-
-
-
Silence Therapeutics (SLN) files for $300M share offering
-
-
-
-
-
-
-
Silence Therapeutics (SLN) Welcomes Tim McInerney to Board of Directors
-
-
-
-
-
-
-
BMO Capital Reiterates Silence Therapeutics (SLN) at Outperform, 'expect a positive Pelacarsen readout to drive 100-200%+ upside"
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)
-
-
-
-
-
470,977 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


